Hull, MA, United States of America

Luigi Anzalone

This inventor holds 1 USPTO granted patent. Top assignee: Empathbio, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luigi Anzalone. Retrieved from https://idiyas.com/inventor/luigi-anzalone-811s1e9v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luigi Anzalone: Inventor in Pharmaceutical Chemistry

Introduction

Luigi Anzalone is an inventor associated with Hull, Massachusetts, and Empathbio, Inc. His patent work concerns a process for preparing optically active piperonyl amines.

Latest Patents

Anzalone is named on 1 patent: “Preparation of Optically Active Enantiomers of Piperonyl Amines by Resolution of the Diastereomeric Salts.” The patent describes a process for resolving the (S)- and (R)-enantiomers of a compound of Formula (I), with the relevant substituents defined in the patent.

Career Highlights

The available information identifies Anzalone’s work at Empathbio, Inc., and his contribution to an invention involving the resolution of diastereomeric salts. This approach is relevant to producing specific enantiomers, which can be important in pharmaceutical research and development.

Collaborations

Anzalone’s listed coworker is Nicholas Morra. Their association reflects a professional connection in the context of Empathbio, Inc., and its innovation activities.

Conclusion

Luigi Anzalone’s recorded patent contribution focuses on a method for resolving optically active piperonyl amines, highlighting his involvement in pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…